Metformin discontinuation in patients undergoing percutaneous coronary interventions – do we have EBM in that field? Review article
Article Sidebar
Published:
Mar 31, 2012
Keywords:
metformin, lactic acidosis, contrast media, renal insufficiency, contrast induced nephropathy, guidelines
Main Article Content
Abstract
Metformin widely used drug to treat type 2 diabetes, may increase the risk of lactic acidosis in patients undergoing percutaneous coronary interventions who are receiving contrast media. The scientific guidelines for patients treated with metformin, are inconsistent and reflect poor EBM in the field.
Article Details
How to Cite
Chmielewski , M., & Janiszewski , M. (2012). Metformin discontinuation in patients undergoing percutaneous coronary interventions – do we have EBM in that field?. Medycyna Faktow (J EBM), 5(1(14), 72-75. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2496
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Maznyczka A., Myat A., Gershlick A.: Discontinuation of metformin in the setting of coronary angiography: clinical uncertainty amongst physicians reflecting a poor evidence base. EuroIntervention 2012 Jan; 7(9): 1103-10.
2. Guidelines on myocardial revascularization. Eur. Heart J. 2010 Oct; 31(20): 2501-55.
3. Salpeter S.R., Greyber E., Pasternak G.A., Salpeter E.E.: Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2010; 4: CD002967.
4. Stades A.M., Heikens J.T., Erkelens D.W., Holleman F., Hoekstra J.B.: Metformin and lactic acidosis: cause or coincidence? A review of case reports.\ J. Intern. Med. 2004 Feb; 255(2): 179-87.
5. McCartney M.M., Gilbert F.J., Murchison L.E., Pearson D., McHardy K., Murray A.D.: Metformin and contrast media – a dangerous combination? Clin. Radiol. 1999 Jan; 54(1): 29-33.
2. Guidelines on myocardial revascularization. Eur. Heart J. 2010 Oct; 31(20): 2501-55.
3. Salpeter S.R., Greyber E., Pasternak G.A., Salpeter E.E.: Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2010; 4: CD002967.
4. Stades A.M., Heikens J.T., Erkelens D.W., Holleman F., Hoekstra J.B.: Metformin and lactic acidosis: cause or coincidence? A review of case reports.\ J. Intern. Med. 2004 Feb; 255(2): 179-87.
5. McCartney M.M., Gilbert F.J., Murchison L.E., Pearson D., McHardy K., Murray A.D.: Metformin and contrast media – a dangerous combination? Clin. Radiol. 1999 Jan; 54(1): 29-33.